We are live on
!
Find out more
AACR
ACR Alpine Capital Research Portfolio holdings
AUM
$6.7B
1-Year Est. Return
33.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+33.44%
3 Year Est. Return
+61.38%
5 Year Est. Return
+53.14%
10 Year Est. Return
+201.58%
AUM
$600M
AUM Growth
+$105M
(+21%)
Cap. Flow
+$80.8M
Cap. Flow
% of AUM
13.45%
Top 10 Holdings %
Top 10 Hldgs %
87.89%
Holding
27
New
7
Increased
15
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RFP
Resolute Forest Products Inc.
RFP
|
+$15.2M |
| 2 |
Walmart Inc
WMT
|
+$13.6M |
| 3 |
Johnson & Johnson
JNJ
|
+$11.4M |
| 4 |
Vodafone
VOD
|
+$6.59M |
| 5 |
Sysco
SYY
|
+$6.15M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.22% |
| 2 | Technology | 19.69% |
| 3 | Consumer Staples | 15.88% |
| 4 | Financials | 15.52% |
| 5 | Industrials | 8.5% |
Similar funds
MSE
MIP
FLPIM
BHM
SPS
SPC
TAM
TB
ACR Alpine Capital Research's Q1 2014 Portfolio in Review
As of Q1 2014, ACR Alpine Capital Research held 27 positions worth $600M, up 21% from $496M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
ACR Alpine Capital Research deployed $80.8M of net new capital in Q1 2014, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was MetLife: 7,293 shares worth $343K.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Staples.
- ACR Alpine Capital Research's largest Q1 2014 buy was MetLife: 7,293 shares worth $343K.
- ACR Alpine Capital Research added most to Resolute Forest Products Inc. in Q1 2014, an estimated $15.2M increase.
- ACR Alpine Capital Research's ten largest holdings make up 88% of its $600M portfolio in Q1 2014.
- ACR Alpine Capital Research opened 7 new positions and closed 0 in Q1 2014.
- ACR Alpine Capital Research's portfolio value rose 21% quarter-over-quarter to $600M.
Based on ACR Alpine Capital Research's 13F filing for Q1 2014, filed 12 May 2014.